Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P2B001 in Early Parkinson's Disease
NCT03329508Phase 3Completed
- Sponsor
- Pharma Two B
- Start
- Jan 2018
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of pramipexole + rasagiline in Parkinson's disease (PD), sponsored by Pharma Two B. Started Jan 2018; status: completed.
02
Drugs
pramipexole + rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03329508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03329508.